MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

Pfizer

Chiusa

SettoreSettore sanitario

25.68 -2.21

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

25.63

Massimo

26.47

Metriche Chiave

By Trading Economics

Entrata

-45M

2.9B

Vendite

938M

15B

P/E

Media del settore

13.984

37.257

EPS

0.78

Rendimento da dividendi

6.21

Margine di Profitto

19.982

Dipendenti

81,000

EBITDA

266M

5.3B

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+8.6% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

6.21%

2.94%

Utili prossimi

4 nov 2025

Prossima data del Dividendo

1 dic 2025

Prossima data del' Ex Dividendo

7 nov 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

16B

150B

Apertura precedente

27.89

Chiusura precedente

25.68

Notizie sul Sentiment di mercato

By Acuity

40%

60%

163 / 371 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bullish Evidence

Pfizer Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

1 ott 2025, 08:54 UTC

I principali Market Mover

Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site

30 set 2025, 15:07 UTC

I principali Market Mover

Pfizer Shares Rise After WSJ Reports Company Will Lower Drug Costs

22 set 2025, 14:54 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- 2nd Update

22 set 2025, 11:51 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- Update

22 set 2025, 11:09 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion

22 set 2025, 10:13 UTC

I principali Market Mover
Acquisizioni, Fusioni, Takeovers

Metsera Shares Leap Premarket on Report of Takeover by Pfizer

22 set 2025, 07:42 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer Nears $7.3 Billion Metsera Deal, FT Says, Citing Sources

5 ago 2025, 11:34 UTC

Utili

Pfizer Boosts 2025 Adjusted EPS Outlook Following 2Q Gains

22 set 2025, 15:17 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer Jumps Back into the Weight-Loss Race With $4.9B Acquisition -- Barrons.com

22 set 2025, 13:43 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- Update

22 set 2025, 11:26 UTC

Acquisizioni, Fusioni, Takeovers

These Stocks Are Moving the Most Today: Fox, Coinbase, Metsera, Pfizer, Kenvue, Anywhere Real Estate, Premier, and More -- Barrons.com

22 set 2025, 11:26 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- WSJ

22 set 2025, 10:48 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer: Metsera Deal Adds Four Clinical-Stage Incretin, Amylin Programs to Pipeline >PFE MTSR

22 set 2025, 10:47 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer: Metsera Deal Includes Contingent Value Rights Worth Up to Additional $22.50/Share >PFE MTSR

22 set 2025, 10:46 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer: Metsera Deal Has Initial Enterprise Value of $4.9 Billion >PFE MTSR

22 set 2025, 10:45 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer to Pay Initial $47.50/Share for Metsera >PFE MTSR

22 set 2025, 10:45 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer to Acquire Metsera and Its Next-Generation Obesity Portfolio >PFE MTSR

22 set 2025, 09:12 UTC

Azioni calde

Stocks to Watch Monday: Nippon Steel, Porsche, Infosys, Metsera -- WSJ

5 ago 2025, 20:44 UTC

Utili

These Stocks Moved the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5 ago 2025, 18:20 UTC

Utili

Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain. -- Barrons.com

5 ago 2025, 18:17 UTC

Utili

These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5 ago 2025, 16:04 UTC

Discorsi di Mercato

Pfizer's New Tax Rate Helps Boost Adj EPS Outlook -- Market Talk

5 ago 2025, 15:25 UTC

Utili

Correction to These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Caterpillar, BP, and More -- Barrons.com

5 ago 2025, 13:56 UTC

Utili

Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain. -- Barrons.com

5 ago 2025, 11:43 UTC

Utili

Pfizer Stock Pops as Earnings Smash Expectations. Guidance Hiked in Face of Tariffs. -- Barrons.com

5 ago 2025, 11:27 UTC

Utili

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5 ago 2025, 10:57 UTC

Utili

Pfizer Stock Pops as Earnings Smash Expectations. Why the Outlook Has Been Hiked. -- Barrons.com

5 ago 2025, 10:55 UTC

Utili

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5 ago 2025, 10:53 UTC

Utili

Pfizer Boosts 2025 Profit Estimate In A Sign Of 'Confidence' -- MarketWatch

5 ago 2025, 10:51 UTC

Utili

Pfizer: On Track to Deliver About $7.2B Overall Cost Savings From Cost-Improvement Initiatives b/ End of 2027 >PFE

Confronto tra pari

Modifica del prezzo

Pfizer Previsione

Obiettivo di Prezzo

By TipRanks

8.6% in crescita

Previsioni per 12 mesi

Media 28.53 USD  8.6%

Alto 34 USD

Basso 24 USD

Basato su 17 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Pfizer - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

17 ratings

4

Acquista

12

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

22.855 / 23.85Supporto e resistenza

A breve termine

Bullish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

163 / 371 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
help-icon Live chat